Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1100% Oxygen1件: Oxygen1件: Oxygen 💬 --6件: 13, 15, 36, 96, 97, 269 💬
2ABC008----1件: 15 💬
3ADSVF----2件: 15, 96 💬
4ALEMTUZUMAB1件: Alemtuzumab1件: Alemtuzumab 💬 --21件: 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
5Alemtuzumab (Campath)1件: Alemtuzumab1件: Alemtuzumab 💬 --1件: 15 💬
6Anakinra1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬22件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
7ARIMOCLOMOL1件: Arimoclomol2件: Arimoclomol ,
Arimoclomol citrate 💬 		--3件: 2, 15, 19 💬
8Arimoclomol citrate1件: Arimoclomol2件: Arimoclomol ,
Arimoclomol citrate 💬 		--2件: 15, 19 💬
9Bimagrumab1件: Bimagrumab1件: Bimagrumab 💬 2件: ACVR2A,
ACVR2B 💬 		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
10BOTULINUM TOXIN TYPE A1件: Botulinum toxin type A4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
11BRX-345----2件: 2, 15 💬
12BYM338----1件: 15 💬
13BYM338 (Bimagrumab)1件: Bimagrumab1件: Bimagrumab 💬 2件: ACVR2A,
ACVR2B 💬 		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
14BYM338/bimagrumab1件: Bimagrumab1件: Bimagrumab 💬 2件: ACVR2A,
ACVR2B 💬 		4件: Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Signaling pathways regulating pluripotency of stem cells, TGF-beta signaling pathway 💬1件: 15 💬
15Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
16Care as usual----1件: 15 💬
17Cemdisiran1件: Cemdisiran---6件: 11, 15, 62, 66, 109, 223 💬
18Combination Product: Pozelimab/Cemdisiran2件: Cemdisiran,
Pozelimab		1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 15 💬
19Creatine1件: Creatine---18件: 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
20Diagnostic Test: Beck depression inventory fast screen (Questionnaire)----3件: 3, 15, 256 💬
21Diagnostic Test: Borg Scale----3件: 3, 15, 256 💬
22Diagnostic Test: Brief Pain Inventory (BPI) (Questionnaire)----3件: 3, 15, 256 💬
23Diagnostic Test: Fatigue Severity and Disability Scale (FSS) (Questionnaire)----3件: 3, 15, 256 💬
24Diagnostic Test: German Pain Inventory (Questionnaire)----3件: 3, 15, 256 💬
25Diagnostic Test: Handheld Dynamometry (HHD)----3件: 3, 15, 256 💬
26Diagnostic Test: Laboratory assessment: calcium1件: Calcium---3件: 3, 15, 256 💬
27Diagnostic Test: Laboratory assessment: Creatine kinase1件: Creatine---3件: 3, 15, 256 💬
28Diagnostic Test: Laboratory assessment: magnesium1件: Magnesium---3件: 3, 15, 256 💬
29Diagnostic Test: Laboratory assessment: phosphate----3件: 3, 15, 256 💬
30Diagnostic Test: Laboratory assessment: Vitamin D Level1件: Vitamin D---3件: 3, 15, 256 💬
31Diagnostic Test: Muscle ultrasound----5件: 3, 15, 111, 113, 256 💬
32Diagnostic Test: Pressure pain threshold----4件: 3, 15, 113, 256 💬
33Diagnostic Test: Quick Motor Function Test----4件: 3, 15, 113, 256 💬
34Diagnostic Test: R-PAct (Questionnaire)----3件: 3, 15, 256 💬
35Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire)----3件: 3, 15, 256 💬
36Diagnostic Test: Six-minute walk test (6MWT)----3件: 3, 15, 256 💬
37Diagnostic Test: Vital signs----3件: 3, 15, 256 💬
38Etanercept1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬16件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285, 298 💬
39FLEBOGAMMA 5%----1件: 15 💬
40Gamma Globulin----2件: 15, 50 💬
41Genetic: Blood draw for optional genetic exome sequencing----3件: 3, 15, 256 💬
42Genetic: Genetic test: ACE polymorphism----3件: 3, 15, 256 💬
43Genetic: Genetic test: ACTN3 polymorphism----3件: 3, 15, 256 💬
44Hyperbaric oxygen treatment (HBOT)1件: Oxygen1件: Oxygen 💬 --6件: 13, 15, 36, 96, 97, 269 💬
45Immunoglobulins, normal human, for intravascular adm.----2件: 14, 15 💬
46Magnesium1件: Magnesium---23件: 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
47NATALIZUMAB1件: Natalizumab1件: Natalizumab 💬 1件: ITGA4 💬 17件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection 💬5件: 13, 15, 25, 46, 96 💬
48Other: Anthropometry----1件: 15 💬
49Other: Behavioural Monitoring----1件: 15 💬
50Other: Blood collection----7件: 15, 28, 36, 49, 66, 67, 223 💬
51Other: Blood-flow restricted training----1件: 15 💬
52Other: Capillary Blood Sampling----1件: 15 💬
53Other: Dynamometry----1件: 15 💬
54Other: Indirect Calorimetry----1件: 15 💬
55Other: Magnetic Resonance Imaging----2件: 13, 15 💬
56Oxygen1件: Oxygen1件: Oxygen 💬 --30件: 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
57Phenylbutyrate Oral Tablet----1件: 15 💬
58Pioglitazone1件: Pioglitazone2件: Pioglitazone hydrochloride ,
Pioglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 81, 86, 96, 223, 229, 265, 298, 299 💬
59Pozelimab1件: Pozelimab1件: Pozelimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬3件: 11, 15, 62 💬
60RAAV1.CMV.huFollistatin344----2件: 15, 113 💬
61Radiation: Whole-Body Dual-Energy X-ray Absorptiometry----1件: 15 💬
62Rapamycin1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬13件: 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
63REGN2477+REGN1033----1件: 15 💬
64Ruxolitinib1件: Ruxolitinib2件: Ruxolitinib ,
Ruxolitinib phosphate 💬 		2件: JAK1,
JAK2 💬 		37件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬7件: 13, 15, 50, 60, 65, 228, 331 💬
65Simvastatin1件: Simvastatin1件: Simvastatin 💬 1件: HMGCR 💬 3件: AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬22件: 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
66Sirolimus1件: Sirolimus1件: Sirolimus 💬 1件: MTOR 💬 52件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬46件: 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
67SIVASTIN----1件: 15 💬
68Ulviprubart1件: Ulviprubart1件: Ulviprubart 💬 --1件: 15 💬
69Ulviprubart (ABC008)1件: Ulviprubart1件: Ulviprubart 💬 --1件: 15 💬
70Vitamin D1件: Vitamin D---26件: 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
71Xeomin----7件: 5, 6, 7, 13, 15, 17, 113 💬